SNCA and Parkinson disease: Next to transgenic mouse models, recombinant adeno-associated viral vector- (rAAV-) based α-synuclein rodent and primate models, presenting various degrees of neuronal cell loss, have extended our view on neuroinflammatory events in PD pathogenesis.